December 3, 2020 Health Policy As more is learned about Sars-CoV-2 incubation periods, quarantine health policy recommendations can change.
December 2, 2020 Allergy/Immunology Antibody testing for COVID-19 may satisfy your curiosity and provide a false sense of protection but will not change the outcome of what we need to continue to do. Not enough is known about immunity duration or transmission potential after infection.
November 30, 2020 Health Policy What should the public health policy strategy be if someone refuses to be vaccinated against Sars-CoV-2?
November 29, 2020 Sunday House Call Shows Sunday House Call, #767, November 29, 2020: The thinking behind rapid testing and why we should do this now.
November 27, 2020 Epidemiology There comes a point when dire modelling scenarios will fail to have the desired impact on a bludgeoned portion of the population that are doing their part. 8 months in, those who haven’t will carry on snubbing the recommendations. Next message strategy?
November 20, 2020 Epidemiology How can a limited vaccine supply effectively be employed to maximally reduce the rate of spread and protect the vulnerable? Network scientists have a counterintuitive proposal.
November 16, 2020 Allergy/Immunology Study shows ten percent of people, mostly men, with severe COVID-19, develop an autoimmune response that attacks interferons (part of the immune system) thereby reducing the host’s ability to defend against the virus.
November 13, 2020 Epidemiology Little being done to mitigate the unsurprising exponential increase of Covid-19 cases in Ontario. Why not employ successful measures that other countries are using to protect their citizens and remain economically functional?
November 11, 2020 Epidemiology Observational study suggests that one-fifth of Covid-19 patients get a psychiatric diagnosis within 90 days. Many factors confound the results. Need more evidence and biological mechanism to determine if there is a causal link.
November 6, 2020 Health Policy National Advisory Committee on Immunization prioritizes four groups to first receive Covid-19 vaccine but does not provide the distribution framework whilst the National Academies of Sciences, Engineering, and Medicine does so with caveats.
